NATR - NATURES SUNSHINE PRODUCTS INC


25.08
-0.050   -0.199%

Share volume: 134,778
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.17%

PREVIOUS CLOSE
CHG
CHG%

$25.13
-0.05
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
35%
Profitability 4%
Dept financing 35%
Liquidity 57%
Performance 61%
Company vs Stock growth
vs
Performance
5 Days
0.08%
1 Month
-4.06%
3 Months
13.13%
6 Months
47.18%
1 Year
72.97%
2 Year
45.48%
Key data
Stock price
$25.08
P/E Ratio 
18.13
DAY RANGE
$25.00 - $26.00
EPS 
$0.84
52 WEEK RANGE
$11.01 - $28.14
52 WEEK CHANGE
$85.50
MARKET CAP 
273.704 M
YIELD 
N/A
SHARES OUTSTANDING 
17.496 M
DIVIDEND
$1.00
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-06-2025
BETA 
1.12
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$118,474
AVERAGE 30 VOLUME 
$118,517
Company detail
CEO: Terrence O. Moorehead
Region: US
Website: naturessunshine.com
Employees: 850
IPO year: 2007
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Nature's Sunshine Products, Inc. manufactures and sells nutritional and personal care products. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company was founded in 1972 and is headquartered in Lehi, Utah.

Recent news